Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
3D Biotek
AddedFeb 16, 2024
UpdatedJun 18, 2026
3D Biotek

3D Biotek

Angel

3D Biotek LLC: A biotech firm specializing in manufacturing 3D cell culture devices since 2007.

HQ
North Brunswick, NJ, US
Founded
2007
Overview
Compare
Fundraising
Employees
Website

3D Biotek LLC, founded in 2007, is a high-tech biomedical engineering company based in New Jersey, USA. The company specializes in manufacturing 3D cell culture devices utilizing its Precision 3D Micro-Fabrication Technology and Advanced Bio-Manufacturing Technology. These devices are pivotal for stem cell and tissue engineering, drug discovery, and various cell biology applications. 3D Biotek aims to revolutionize biomedical research by offering innovative solutions that enhance the accuracy and efficiency of cell culture processes.

3D Biotek has established itself as a leader in the biotechnology sector, being the industry's only dedicated driving force in the development of three-dimensional cell culture devices. The company's products have significantly impacted research methodologies, providing more reliable and scalable options for scientists and researchers. Through continuous innovation and dedication to quality, 3D Biotek has contributed to advancements in drug discovery and tissue engineering, solidifying its reputation as a key player in the biomedical field.

3D Biotek - Quick Facts

When was 3D Biotek founded?

3D Biotek was founded in 2007.

Where is 3D Biotek's headquarters located?

3D Biotek's headquarters is located in North Brunswick, NJ, US.

When was 3D Biotek's last funding round?

3D Biotek's most recent funding round was for $225k (USD) in November 2013.

How much has 3D Biotek raised to-date?

As of Nov 27, 2013, 3D Biotek has raised a total of $225k (USD).

How many employees does 3D Biotek have?

3D Biotek has 4 employees as of Feb 4, 2024.

3D Biotek - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Software
  • Transactional
Customer
  • Enterprise
Main Product
  • Bioprinting
  • Cell Culture
Tags
  • Healthtech
  • Research
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified